Clinical Trial Update: Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study [Phase 2]

View source ↗

Summary

Phase 2 dose-finding clinical trial investigating brexanolone for co-occurring post-traumatic stress disorder and alcohol use disorder in veterans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Brexanolone (allopregnanolone)

Snippet

Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | Conditions: Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD) | Phase 2 | Status: NOT_YET_RECRUITING